What patients think and understand can impact their decisions and their outcomes

It has long been appreciated that African-American males have higher risk for diagnosis with prostate cancer, and higher risk for prostate cancer-specific mortality, than those of other ethnic origins living in the US. … READ MORE …

Of race and definitive treatment after diagnosis of prostate cancer

A new article in Urology (“the Gold Journal”) has again pointed out the race-related discrepancies between the application of definitive treatments for prostate cancer, particularly between Caucasian-American and African-American men. … READ MORE …

Race, disparities, and end-of-life care for prostate cancer patients

A newly published paper in the Journal of the National Comprehensive Cancer Network has identified a series of significant disparities in there clinical care of African American men as opposed to Caucasians. … READ MORE …

PPACA, cancer disparities, and health care reform

As reported last Friday on the Medscape web site, the American Society for Clinical Oncology (ASCO) has recently issued a new policy statement addressing the opportunities presented by the Patient Protection and Affordable Care Act (PPACA) to reduce the disparities in cancer care. … READ MORE …

Your Wednesday news summary: November 19, 2008

Today’s reports cover such items as:

  • Disparities in cancer mortality between blacks and whites in the USA
  • Body mass, body fat distribution, and risk for prostate cancer
  • Risk for cancer in male carriers of BRCA mutations
  • A five-SNP genetic marker set and prostate cancer risk
  • Final results of the atrasentan trial in non-metastatic, HRPC patients
  • Is a rising plasma PDGF level an indicator for docetaxel failure? … READ MORE …